School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, OH, USA.
COPD. 2022;19(1):142-148. doi: 10.1080/15412555.2022.2049736.
Spirometry is necessary to diagnose chronic obstructive pulmonary disease (COPD), yet a large proportion of patients are diagnosed and treated without having received testing. This study explored whether the effects of interventions using the electronic health record (EHR) to target patients diagnosed with COPD without confirmatory spirometry impacted the incidence rates of spirometry referrals and completions. This retrospective before and after study assessed the impact of provider-facing clinical decision support that identified patients who had a diagnosis of COPD but had not received spirometry. Spirometry referrals, completions, and results were ascertained 1.5 years prior to and 1.5 years after the interventions were initiated. Inhaler prescriptions by class were also tallied. There were 10,949 unique patients with a diagnosis of COPD who were eligible for inclusion. 4,895 patients (44.7%) were excluded because they had completed spirometry prior to the cohort start dates. The pre-intervention cohort consisted of 2,622 patients, while the post-intervention cohort had 3,392. Spirometry referral rates pre-intervention were 20.2% compared to 31.6% post-intervention ( < 0.001). Spirometry completion rates rose from 13.2% pre-intervention to 19.3% afterwards ( < 0.001). 61.7% (585 of 948) had no evidence of airflow obstruction. After excluding patients with a diagnosis of asthma, 25.8% (126 of 488) patients who had no evidence of airflow obstruction had prescriptions for long-acting bronchodilators or inhaled steroids. A concerted EHR intervention modestly increased spirometry referral and completion rates in patients with a diagnosis of COPD without prior spirometry and decreased misclassification of disease.
肺量测定对于诊断慢性阻塞性肺疾病(COPD)是必要的,但很大一部分患者在未经检测的情况下被诊断和治疗。本研究探讨了使用电子健康记录(EHR)针对未经确认的肺量测定诊断为 COPD 的患者进行干预,是否会影响肺量测定转介和完成的发生率。这项回顾性的前后研究评估了针对已经诊断为 COPD 但尚未接受肺量测定的患者的面向提供者的临床决策支持的影响。在干预措施开始前和开始后 1.5 年,确定了肺量测定转介、完成和结果。还统计了按类别的吸入器处方。有 10949 名符合条件的 COPD 诊断的独特患者。4895 名患者(44.7%)因在队列开始日期前已完成肺量测定而被排除在外。前干预队列包括 2622 名患者,而后干预队列有 3392 名。前干预组的肺量测定转介率为 20.2%,而干预后组为 31.6%(<0.001)。肺量测定完成率从干预前的 13.2%上升到干预后的 19.3%(<0.001)。61.7%(948 例中的 585 例)无气流阻塞证据。在排除诊断为哮喘的患者后,488 例无气流阻塞证据的患者中有 25.8%(126 例)开有长效支气管扩张剂或吸入性类固醇处方。一项协调一致的 EHR 干预措施适度增加了未经先前肺量测定诊断为 COPD 的患者的肺量测定转介和完成率,并减少了疾病的误诊。